GlobeNews Wire

PharmAla Issues Q3 Financial Statements

TORONTO, July 25, 2025 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”) (CSE: MDMA) (OTC: MDXXF), a…

9 months ago

Calidi announces Reverse Stock Split, expected to begin trading on a 1-for-12 split adjusted basis onAugust 5, 2025

SAN DIEGO, July 25, 2025 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics, Inc. (“Calidi” or the “Company”) (NYSE American: CLDI), a clinical-stage…

9 months ago

Ambow Launches HybriU Global Learning Network, Connecting U.S. Universities with Students Worldwide

New Phygital Infrastructure Empowers U.S. Universities to Expand Globally Through AI-powered Hybrid Classrooms      CUPERTINO, Calif., July 25, 2025 (GLOBE NEWSWIRE)…

9 months ago

Aurora Mobile Leverages Quantum Computing to Accelerate Business Model Innovation

July 25, 2025 05:00 ET  | Source: Aurora Mobile Limited SHENZHEN, China, July 25, 2025 (GLOBE NEWSWIRE) -- Aurora Mobile…

9 months ago

Nrburgring chooses vivenu: New partnership accelerates ticketing innovation

DÜSSELDORF, Germany and NÜRBURG, Germany, July 25, 2025 (GLOBE NEWSWIRE) -- Nürburgring, Germany’s largest sporting venue and one of the…

9 months ago

Pfizer and BioNTech Receive Positive CHMP Opinion for LP.8.1-Adapted COVID-19 Vaccine in the European Union

Data indicate that the LP.8.1-adapted COVID-19 vaccine confers improved immune response against currently dominant and emerging sublineages – including the…

9 months ago

Abivax Announces Full Exercise of Underwriters Option to Purchase Additional ADSs, Bringing Gross Proceeds of Offering to $747.5M (637.5M)

Abivax Announces Full Exercise of Underwriters’ Option to Purchase Additional ADSs, Bringing Gross Proceeds of Offering to $747.5M (€637.5M) PARIS,…

9 months ago

Press Release: Sanofis Sarclisa approved in the EU for the treatment of transplant-eligible newly diagnosed multiple myeloma

Sanofi’s Sarclisa approved in the EU for the treatment of transplant-eligible newly diagnosed multiple myeloma Approval based on GMMG-HD7 phase…

9 months ago

The Joint Corp. to Host Conference Call on Thursday, August 7thto Discuss Second Quarter 2025 Results

July 24, 2025 07:05 ET  | Source: The Joint Corp. SCOTTSDALE, Ariz., July 24, 2025 (GLOBE NEWSWIRE) -- The Joint…

9 months ago

INmune Bio to Present Phase 2 MINDFuL Trial Findings of XPro at the Alzheimers Association International Conference

July 24, 2025 07:00 ET  | Source: INmune Bio, Inc. Boca Raton, July 24, 2025 (GLOBE NEWSWIRE) -- INmune Bio…

9 months ago